EUVIMEDEUVIMED entdecken
Open Access

Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency

Britta Weber, Katherine Paton, Roy Ma, Tom Pickles

Ocular Oncology and Pathology · 2016 · 2 (1) · 29-35

DOI: 10.1159/000433546 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 09.07.2015. Verfasst von Britta Weber und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, B.C., Canada; Department of Oncology, Aarhus Univer…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose: To report outcomes and toxicity after proton beam radiotherapy for non-peripapillary choroidal and ciliary body melanoma considered unsuitable for other eye-sparing therapies. Materials and Methods: An existing database of 77 patients with non-peripapillary tumors treated at TRIUMF, Canada, including patient, tumor, and treatment characteristics, was updated with ocular complications and follow-up status from chart reviews.

Results

Most of the patients had large tumors: 61% were T3/T4 tumors (AJCC classification), while 48% were large by the Collaborative Ocular Melanoma Study classification. The median thickness was 7.1 mm, and the ciliary body was involved in 35%. After 5 and 10 years, the actuarial ocular tumor control rate was 85 and 85%, metastasis-free survival was 72 and 57%, overall survival was 77 and 63%, the enucleation rate was 22 and 22%, and complete blindness was found in 38 and 38%, respectively. On univariate analysis, patients with ciliary body involvement had significantly worse metastasis-free survival and overall survival rates compared to patients without ciliary body involvement (p < 0.001).

Conclusions

Proton therapy for large anteriorly located tumors resulted in acceptable ocular tumor control and survival rates. The risk of blindness and severe toxicity requiring enucleation was low, and a substantial proportion of patients maintained useful vision.

Schlagwörter

Stichwörter der Autor:innen

Ciliary bodyOutcomesProton therapyToxicityUveal melanoma

Autor:innen und Institutionen

  • Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, B.C., Canada; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Ophthalmology and Visual Sciences, Vancouver Hospital Eye Care Center and University of British Columbia, Vancouver, B.C., Canada.
  • Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver, B.C., Canada.

Zitieren

APA

Weber, B., Paton, K., Ma, R., & Pickles, T. (2016). Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency. Ocular Oncology and Pathology, 2(1), 29-35. https://doi.org/10.1159/000433546

Vancouver

Weber B, Paton K, Ma R, Pickles T. Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency. Ocular Oncology and Pathology. 2016;2(1):29-35. doi:10.1159/000433546

BibTeX
@article{Weber2016,
  author = {Weber, Britta and Paton, Katherine and Ma, Roy and Pickles, Tom},
  title = {Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency},
  journal = {Ocular Oncology and Pathology},
  year = {2016},
  volume = {2},
  number = {1},
  pages = {29--35},
  doi = {10.1159/000433546}
}
Kostenlos starten →